Harvard University

Taking GLP-1s during the first trimester of pregnancy does not appear to substantially increase the risk of adverse outcomes.

GLP-1 use during early pregnancy may not increase risk of major adverse outcomes | Harvard T.H. Chan School of Public Health Taking GLP-1s during the first trimester of pregnancy does not appear to increase the risk of major adverse outcomes such as non-live birth, according to a new Harvard Chan School study.

Short bursts of walking over the course of the day can boost metabolism.

Micro walks can have big health benefits, expert says | Harvard T.H. Chan School of Public Health Intense workouts aren’t the only way to reap the benefits of regular exercise.

Harvard researchers and scholars are exploring the physical, societal, and spiritual aspects of growing older.

Informed Aging - Harvard University Harvard scientists are working to not only improve the amount of years we live, but how healthy we can be throughout them.